Perfil
Lyndsey Scull worked as a Director of Corporate Communications at Magenta Therapeutics, Inc. from 2019 to 2021.
Antiguos cargos conocidos de Lyndsey Scull.
| Empresas | Cargo | Fin |
|---|---|---|
| MAGENTA THERAPEUTICS | Contacto de Relaciones con Inversores | 01/10/2021 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
17
Relaciones de 1er grado
1
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Lyndsey Scull